When.com Web Search

  1. Ads

    related to: carbidopa levodopa indications

Search results

  1. Results From The WOW.Com Content Network
  2. Carbidopa/levodopa - Wikipedia

    en.wikipedia.org/wiki/Carbidopa/levodopa

    Carbidopa/levodopa, also known as levocarb and co-careldopa, is the combination of the two medications carbidopa and levodopa. [6] It is primarily used to manage the symptoms of Parkinson's disease , but it does not slow down the disease or stop it from getting worse. [ 6 ]

  3. Carbidopa/levodopa/entacapone - Wikipedia

    en.wikipedia.org/wiki/Carbidopa/levodopa/entacapone

    Levodopa is the immediate precursor to dopamine. Entacapone is a selective, reversible catechol-O-methyltransferase (COMT) inhibitor that prevents the degradation of levodopa.

  4. Carbidopa - Wikipedia

    en.wikipedia.org/wiki/Carbidopa

    Carbidopa (Lodosyn) is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa.This property is significant in that it allows a greater proportion of administered levodopa to cross the blood–brain barrier for central nervous system effect, instead of being peripherally metabolised into substances unable to cross said barrier.

  5. FDA Issues Complete Response Letter for RYTARY™ (Carbidopa ...

    www.aol.com/news/2013-01-21-fda-issues-complete...

    FDA Issues Complete Response Letter for RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules (IPX066) New Drug Application HAYWARD, Calif.--(BUSINESS WIRE)-- Impax Pharmaceuticals, a ...

  6. Impax Pharmaceuticals Announces Presentation of RYTARY TM (IPX066) (Carbidopa and Levodopa) Extended-Release Capsules Phase III and Open-Label Extension Data at the American Academy of Neurology ...

  7. L-DOPA - Wikipedia

    en.wikipedia.org/wiki/L-DOPA

    L-DOPA is used medically under the name levodopa in the treatment of Parkinson's disease and certain other medical conditions. It is usually used in combination with a peripherally selective aromatic L-amino acid decarboxylase (AAAD) inhibitor such as carbidopa or benserazide. These agents increase the strength and duration of levodopa.